Neoantigen quality predicts immunoediting in survivors of pancreatic cancer

Cancer immunoediting 1 is a hallmark of cancer 2 that predicts that lymphocytes kill more immunogenic cancer cells to cause less immunogenic clones to dominate a population. Although proven in mice 1 , 3 , whether immunoediting occurs naturally in human cancers remains unclear. Here, to address this...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nature (London) Ročník 606; číslo 7913; s. 389 - 395
Hlavní autori:	Łuksza, Marta, Sethna, Zachary M., Rojas, Luis A., Lihm, Jayon, Bravi, Barbara, Elhanati, Yuval, Soares, Kevin, Amisaki, Masataka, Dobrin, Anton, Hoyos, David, Guasp, Pablo, Zebboudj, Abderezak, Yu, Rebecca, Chandra, Adrienne Kaya, Waters, Theresa, Odgerel, Zagaa, Leung, Joanne, Kappagantula, Rajya, Makohon-Moore, Alvin, Johns, Amber, Gill, Anthony, Gigoux, Mathieu, Wolchok, Jedd, Merghoub, Taha, Sadelain, Michel, Patterson, Erin, Monasson, Remi, Mora, Thierry, Walczak, Aleksandra M., Cocco, Simona, Iacobuzio-Donahue, Christine, Greenbaum, Benjamin D., Balachandran, Vinod P.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 09.06.2022 Nature Publishing Group
Predmet:	631/57/2266 631/67/580/1884 631/67/69 Antigens Cancer Cloning Discrimination Evolution Humanities and Social Sciences Hypotheses Immune system Immunogenicity Life Sciences Lymphocytes Lymphocytes T Major histocompatibility complex multidisciplinary Mutation Neoantigens Pancreatic cancer Peptides Physics Science Science (multidisciplinary) Survival T cell receptors Thymus gland Tumors
ISSN:	0028-0836, 1476-4687, 1476-4687
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!